Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07315334) titled 'Assessing Functional Impairments in Patients With Chemotherapy-Induced Peripheral Neuropathy' on Dec. 18, 2025.
Study Type: Observational
Primary Sponsor: Paracelsus Medical University
Condition:
Chemotherapy Induced Peripheral Neuropathy (CIPN)
Intervention:
Diagnostic Test: Questionnaire and Physical Exam
Recruitment Status: Not recruiting
Date of First Enrollment: January 15, 2026
Target Sample Size: 80
To know more, visit https://clinicaltrials.gov/study/NCT07315334
Published by HT Digital Content Services with permission from Health Daily Digest....